Spebrutinib
Product Specifications
CAS Number
1202757-89-8
Target
BTK, Src
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Purity
>99.99%
Bioactivity
Spebrutinib (LMK-435) is an orally bioavailable, selective inhibitor of Bruton's agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
Smiles
COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1
Molecular Formula
C22H22FN5O3
Molecular Weight
423.44
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
